Expression of Hsap\FUSScer\UAS.cMa.T:Ivir\HA1 under the control of Scer\GAL4GMR.PF at 25[o]C results in a very weak abnormal eye phenotype on eclosion, with a defect in the formation of interommatidial bristles. When expressed at 29[o]C, there is a more severe disruption in eye morphology, with a larger number of malformed interommatidial bristles and the appearance of numerous ectopic cell extensions.
Expression of Hsap\FUSScer\UAS.cMa.T:Ivir\HA1 under the control of Scer\GAL4elav.Switch.PO results in a decrease in mean lifespan compared to controls, with the decrease becoming more severe in a dose-dependent manner with increasing concentrations of RU486.
Hsap\FUSUAS.cMa.Tag:HA, Scer\GAL4GMR.PF has visible | heat sensitive phenotype, suppressible by Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\FUSUAS.cMa.Tag:HA, Scer\GAL4elav.Switch.PO has short lived | RU486 conditional phenotype, suppressible | RU486 conditional by Hsap\HSPA1LUAS.cWa, Scer\GAL4elav.Switch.PO
Hsap\FUSUAS.cMa.Tag:HA, Scer\GAL4GMR.PF has interommatidial bristle | heat sensitive phenotype, suppressible by Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Hsap\FUSUAS.cMa.Tag:HA, Scer\GAL4GMR.PF has eye | heat sensitive phenotype, suppressible by Hsap\HSPA1LUAS.cWa, Scer\GAL4GMR.PF
Co-expression of Hsap\HSPA1LScer\UAS.cWa strongly suppresses the eye defects caused by expression of Hsap\FUSScer\UAS.cMa.T:Ivir\HA1 under the control of Scer\GAL4GMR.PF at 29[o]C.
Co-expression of Hsap\HSPA1LScer\UAS.cWa strongly suppresses the decrease in lifespan caused by expression of Hsap\FUSScer\UAS.cMa.T:Ivir\HA1 under the control of Scer\GAL4elav.Switch.PO in the presence of RU486.